News
FDA approves new device that may boost number of lung transplants
On August 12, the U.S. Food and Drug Administration (FDA) approved the XVIVO Perfusion System (XPS) with STEEN Solution, a device for preserving donated…
FDA approves new type of drug for insomnia
On August 13, the U.S. Food and Drug Administration (FDA) approved Belsomra (suvorexant) tablets for treating insomnia. Belsomra is the first approved orexin receptor…
FDA approves new drug for type 2 diabetes
On August 1, the U.S. Food and Drug Administration (FDA) approved Jardiance (empagliflozin) tablets as an addition to diet and exercise to improve glycemic…
FDA approves new drug for skin infections
On August 6, the U.S. Food and Drug Administration (FDA) approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin infections. Read…
FDA approves Afrezza
On June 27, the U.S. Food and Drug Administration (FDA) approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control…
FDA approves drug for treating rare type of non-Hodgkin lymphoma
On July 3, the U.S. Food and Drug Administration (FDA) approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma, a rare…
FDA approves new product to treat hereditary angioedema
On July 16, the U.S. Food and Drug Administration (FDA) approved Ruconest, the first recombinant C1-Esterase Inhibitor product for the treatment of acute attacks…
FDA launches new website for accessing health databases
On June 2, the U.S. Food and Drug Administration (FDA) launched openFDA, a new initiative designed to make it easier for web developers, researchers,…
FDA approves new indication for imaging agent
On June 13, the U.S. Food and Drug Administration (FDA) a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent…
FDA approves new device that may boost number of lung transplants
On August 12, the U.S. Food and Drug Administration (FDA) approved the XVIVO Perfusion System (XPS) with STEEN Solution, a device for…
FDA approves new type of drug for insomnia
On August 13, the U.S. Food and Drug Administration (FDA) approved Belsomra (suvorexant) tablets for treating insomnia. Belsomra is the first approved…
FDA approves new drug for type 2 diabetes
On August 1, the U.S. Food and Drug Administration (FDA) approved Jardiance (empagliflozin) tablets as an addition to diet and exercise to…
FDA approves new drug for skin infections
On August 6, the U.S. Food and Drug Administration (FDA) approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin…
FDA approves Afrezza
On June 27, the U.S. Food and Drug Administration (FDA) approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve…
FDA approves drug for treating rare type of non-Hodgkin lymphoma
On July 3, the U.S. Food and Drug Administration (FDA) approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma,…
FDA approves new product to treat hereditary angioedema
On July 16, the U.S. Food and Drug Administration (FDA) approved Ruconest, the first recombinant C1-Esterase Inhibitor product for the treatment of…
FDA launches new website for accessing health databases
On June 2, the U.S. Food and Drug Administration (FDA) launched openFDA, a new initiative designed to make it easier for web…
FDA approves new indication for imaging agent
On June 13, the U.S. Food and Drug Administration (FDA) a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic…